Delivery Order SPE2DB22D7058-SPE2DB23FSTZ1

Award Date 8/7/23
Potential Completion Date 8/8/23
Potential Value $336
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $83,940 to Amerisourcebergen Drug Corporation. The order is for 500 tablets of the generic cholesterol medication atorvastatin 20 mg. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between August 29-30, 2023. The Defense Logistics Agency routinely issues such orders under its Prime Vendor program to support the medical supply needs of the U.S....
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $27,980 to Amerisourcebergen Drug Corporation. The order is for 500 tablets of the generic cholesterol medication atorvastatin 20 mg. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between August 24-25, 2023. The Defense Logistics Agency routinely procures pharmaceuticals and other medical supplies to support Department of Defense personnel...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $336 to Amerisourcebergen Drug Corporation for the supply of 500 tablets of 20mg atorvastatin. As the prime contractor, Amerisourcebergen will deliver the generic cholesterol-lowering medication to a facility in Conshohocken, Pennsylvania under a one-day period of performance beginning September 21, 2023. The order is placed against an existing DLA contract vehicle to support the agency's procurement of...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,800 to Amerisourcebergen Drug Corporation for 1,000 tablets of atorvastatin 40 mg. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order period of performance is September 12-13, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor in fulfilling this delivery order for...
The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at $149,280 to supply 4561314141 Atorvastatin 80 mg tablets. As the prime contractor, Amerisourcebergen will deliver 90 counts of the generic cholesterol medication to its facility in Conshohocken, Pennsylvania under a one day period of performance from June 22 to June 23, 2023. The order is placed against an existing DLA contract vehicle to support the agency's medical supply...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $42,000 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will supply 500 boxes containing 20 mg tablets of atorvastatin to be delivered from its facility in Conshohocken, Pennsylvania by July 24, 2023. The ordering agency, DLA, manages the Department of Defense's global supply chain and works to provide medical supplies and pharmaceuticals to support military readiness....
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $336 to Amerisourcebergen Drug Corporation for the supply of 500 tablets of 20mg atorvastatin. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the generic cholesterol-lowering medication from its Conshohocken, Pennsylvania facility to the Defense Logistics Agency by September 12, 2023 under the terms of the order. Amerisourcebergen Corporation is the parent company of Amerisourcebergen...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $526 to Amerisourcebergen Drug Corporation. The order is for 1000 tablets of the cholesterol medication atorvastatin 40 mg to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 8, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform as the prime contractor under this delivery issued against an existing DLA contract vehicle. No set...
The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at approximately $571,000 to supply 1,000 boxes of 80mg atorvastatin tablets. As the prime contractor, Amerisourcebergen will deliver the generic cholesterol medication to a facility in Conshohocken, Pennsylvania under a one day period of performance beginning on August 15, 2023. The order is funded through the Defense Logistics Agency to support the Department of Defense's medical...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at fifty-six thousand dollars to Amerisourcebergen Drug Corporation for the supply of five hundred tablets of the generic cholesterol medication atorvastatin. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania within the one-day period of performance specified under the contract. The Defense Logistics Agency routinely issues...
  • SPE2DB22D7058
    Indefinite Delivery Contract
  • SPE2DB22D7058-SPE2DB23FSTZ1
    Delivery Order

The Defense Logistics Agency awarded a firm fixed price delivery order valued at $335.76 to Amerisourcebergen Drug Corp for the provision of 4561722090, described as Atorvastatin 20 mg tablets in 500 count bottles. As the prime contractor, Amerisourcebergen Drug Corp will deliver the generic cholesterol medication from its Conshohocken, Pennsylvania facility to support DLA requirements. Amerisourcebergen Corporation is the identified parent company of Amerisourcebergen Drug Corp. No major subcontractors or set aside designations were indicated. The single day period of performance from August 7-8, 2023 suggests this delivery order was placed under DLA's Pharmaceutical Prime Vendor contract to facilitate timely pharmaceutical supplies for U.S. military and public health needs.

Generated 12/19/23, 9:03 AM